Capital Advantage Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Capital Advantage reduced its stake in Stryker Corporation by 7.43% during the most recent quarter end. The investment management company now holds a total of 2,504 shares of Stryker Corporation which is valued at $289,287 after selling 201 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Stryker Corporation makes up approximately 0.08% of Capital Advantage’s portfolio.

Other Hedge Funds, Including , Sii Investments Incwi added SYK to its portfolio by purchasing 3,011 company shares during the most recent quarter which is valued at $345,723. Stryker Corporation makes up approx 0.03% of Sii Investments Incwi’s portfolio. Sivik Global Healthcare added SYK to its portfolio by purchasing 50,000 company shares during the most recent quarter which is valued at $5,745,000. Stryker Corporation makes up approx 2.69% of Sivik Global Healthcare’s portfolio.Cornerstone Investment Partners reduced its stake in SYK by selling 87 shares or 1.12% in the most recent quarter. The Hedge Fund company now holds 7,714 shares of SYK which is valued at $945,042. Stryker Corporation makes up approx 0.03% of Cornerstone Investment Partners’s portfolio.Atria Investments reduced its stake in SYK by selling 962 shares or 15.76% in the most recent quarter. The Hedge Fund company now holds 5,142 shares of SYK which is valued at $629,946. Stryker Corporation makes up approx 0.07% of Atria Investments’s portfolio.

Stryker Corporation closed down -0.33 points or -0.29% at $113.15 with 11,01,668 shares getting traded on Wednesday. Post opening the session at $113.5, the shares hit an intraday low of $112.66 and an intraday high of $113.635 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.